163,10 €
1,16 % gestern
L&S, 18. Juli, 22:52 Uhr
ISIN
US00287Y1091
Symbol
ABBV
Berichte
Sektor
Industrie

AbbVie Aktie News

Positiv
Seeking Alpha
etwa 4 Stunden alt
Dividend growth stocks can offer a stable way to passively grow one's income, creating long-term compounding wealth over the long run. Today, we are looking at a screening process that focuses on higher yields but ranks higher on dividend safety and consistency for growth. From the hundreds that end up listed, we take a look at some of those that rank on the higher yield end for an initial look.
Positiv
FXEmpire
etwa 13 Stunden alt
AbbVie Inc. (ABBV) has emerged as a strong performer in financial and technical terms, attracting investor attention due to its long-term growth potential. With consistent revenue generation and expansion of its immunology and neuroscience portfolios, the company demonstrates operational strength.
Positiv
24/7 Wall Street
6 Tage alt
There's really no such thing as a “no brainer” stock pick. I'd say that some opportunities are more compelling than others.
Positiv
The Motley Fool
6 Tage alt
What's better than a great dividend? A great dividend that's growing.
Positiv
The Motley Fool
7 Tage alt
Are dividend stocks only for investors nearing or in retirement? Not at all.
Positiv
Seeking Alpha
7 Tage alt
This isn't a buy list. It's a shortlist to help you speed up your research. We've included both U.S. and Canadian names, organized by country. Each company comes with a business summary, plus a bull and bear case to help you assess the fit. Comcast benefits from diversified cash flow through broadband, content creation, and international operations. The business remains cyclical—recessions hit ...
Positiv
The Motley Fool
8 Tage alt
Dividend investing, like most things in life, can be rewarding if done correctly or a headache if you make crucial mistakes. The key to dividend investing is to pick the right types of dividend stocks.
Positiv
Reuters
8 Tage alt
Shares of Glenmark Pharmaceuticals jumped 10% in early trade on Friday, a day after a unit of the Indian drugmaker signed an exclusive licensing deal with U.S. peer AbbVie for its cancer treatment.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen